Funding Rounds
Ermium Therapeutics Series A (2022, $6M)
Ermium TherapeuticsBiotech firm developing treatments for auto-immune diseases.
Summary
Stage: Series A
Raised Amount: $6.04M
Raised Date: 2022-01-01
Stage: Series A
Raised Amount: $6.04M
Raised Date: 2022-01-01
